Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea
Completed
CollaGenex Pharmaceuticals
Phase 3
2002-06-01
The purpose of this study is to determine whether Periostat(R), Doxycycline Hyclate 20 mg
Tablets, taken twice daily is effective in reducing the red and white heads and overall
redness associated with rosacea.
Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens
Completed
CollaGenex Pharmaceuticals
Phase 4
2007-03-01
To compare the safety and efficacy of two treatment regimens: 1) COL-101 and metronidazole
gel 1%; 2) Doxycycline hyclate 100 mg and metronidazole gel 1%
Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate
Completed
Warner Chilcott
Phase 4
2008-03-01
Randomized, multi-center, open label, active-comparator study to compare the efficacy and
tolerability of Doryx Delayed Release Tablets to doxycycline hyclate in patients with
moderate to severe acne vulgaris.
Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance
Completed
Galderma
Phase 3
2008-11-01
The purpose of this study is to demonstrate the efficacy of Adapalene 0.1% /Benzoyl Peroxide
2.5% Gel compared to its Vehicle Gel as an acne maintenance treatment in Subjects previously
treated with Adapalene-BPO Gel or Adapalene-BPO Vehicle Gel both associated with Doxycycline
Hyclate 100 mg. The safety of the two investigational treatments will also be assessed.
Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance
Completed
Galderma R&D
Phase 3
2008-11-01
The purpose of this study is to demonstrate the efficacy of Adapalene 0.1% /Benzoyl Peroxide
2.5% Gel compared to its Vehicle Gel as an acne maintenance treatment in Subjects previously
treated with Adapalene-BPO Gel or Adapalene-BPO Vehicle Gel both associated with Doxycycline
Hyclate 100 mg. The safety of the two investigational treatments will also be assessed.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
